Cargando…
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus
Anti-CD19 chimeric antigen receptor (CAR)-T therapy for B cell malignancies has shown clinical success, but a major limitation is the logistical complexity and high cost of manufacturing autologous cell products. If engineered for improved safety, direct infusion of viral gene transfer vectors to in...
Autores principales: | Rive, Craig M., Yung, Eric, Dreolini, Lisa, Brown, Scott D., May, Christopher G., Woodsworth, Daniel J., Holt, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198363/ https://www.ncbi.nlm.nih.gov/pubmed/35755944 http://dx.doi.org/10.1016/j.omtm.2022.05.006 |
Ejemplares similares
-
Targeted Cell-to-Cell Delivery of Protein Payloads via the Granzyme-Perforin Pathway
por: Woodsworth, Daniel J., et al.
Publicado: (2017) -
Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors
por: Bii, Victor M., et al.
Publicado: (2016) -
Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris
por: Brindley, Melinda A, et al.
Publicado: (2009) -
Engineering a replication-incompetent viral vector for the delivery of therapeutic RNA in crustaceans
por: Alenton, Rod Russel R, et al.
Publicado: (2023) -
The Murmurs of Aortic Incompetence
por: Wall, Cecil
Publicado: (1907)